Standard BioTools Return on Tangible Equity 2012-2025 | LAB
Current and historical return on tangible equity values for Standard BioTools (LAB) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Standard BioTools Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $-0.13B | $0.40B | -31.76% |
| 2025-06-30 | $-0.12B | $0.43B | -30.53% |
| 2025-03-31 | $-0.13B | $0.32B | -34.84% |
| 2024-12-31 | $-0.19B | $0.47B | -44.63% |
| 2024-09-30 | $-0.17B | $0.36B | -55.12% |
| 2024-06-30 | $-0.17B | $0.38B | -69.47% |
| 2024-03-31 | $-0.14B | $0.45B | -83.05% |
| 2023-12-31 | $-0.08B | $0.06B | -97.72% |
| 2023-09-30 | $-0.08B | $0.07B | -83.75% |
| 2023-06-30 | $-0.08B | $0.09B | -79.81% |
| 2023-03-31 | $-0.13B | $0.10B | -108.04% |
| 2022-12-31 | $-0.19B | $0.11B | -273.38% |
| 2022-09-30 | $-0.18B | $0.13B | -560.63% |
| 2022-06-30 | $-0.16B | $0.15B | 1715.79% |
| 2022-03-31 | $-0.12B | $-0.11B | 212.84% |
| 2021-12-31 | $-0.06B | $-0.04B | 181.54% |
| 2021-09-30 | $-0.07B | $-0.04B | 277.55% |
| 2021-06-30 | $-0.06B | $-0.03B | 421.05% |
| 2021-03-31 | $-0.06B | $-0.02B | 497.78% |
| 2020-12-31 | $-0.05B | $-0.01B | 572.97% |
| 2020-09-30 | $-0.05B | $0.00B | 738.46% |
| 2020-06-30 | $-0.06B | $-0.02B | 1100.00% |
| 2020-03-31 | $-0.06B | $-0.01B | -1400.00% |
| 2019-12-31 | $-0.07B | $0.00B | -490.57% |
| 2019-09-30 | $-0.07B | $0.01B | 687.18% |
| 2019-06-30 | $-0.07B | $0.02B | 145.26% |
| 2019-03-31 | $-0.07B | $0.02B | 83.78% |
| 2018-12-31 | $-0.06B | $-0.09B | 48.76% |
| 2018-09-30 | $-0.05B | $-0.14B | 40.22% |
| 2018-06-30 | $-0.06B | $-0.13B | 41.43% |
| 2018-03-31 | $-0.06B | $-0.12B | 40.51% |
| 2017-12-31 | $-0.06B | $-0.14B | 41.74% |
| 2017-09-30 | $-0.07B | $-0.14B | 48.23% |
| 2017-06-30 | $-0.07B | $-0.15B | 52.65% |
| 2017-03-31 | $-0.07B | $-0.14B | 59.44% |
| 2016-12-31 | $-0.08B | $-0.13B | 68.75% |
| 2016-09-30 | $-0.07B | $-0.12B | 72.54% |
| 2016-06-30 | $-0.06B | $-0.11B | 69.32% |
| 2016-03-31 | $-0.06B | $-0.09B | 72.61% |
| 2015-12-31 | $-0.05B | $-0.08B | 75.18% |
| 2015-09-30 | $-0.05B | $-0.07B | 79.07% |
| 2015-06-30 | $-0.06B | $-0.07B | 93.72% |
| 2015-03-31 | $-0.05B | $-0.06B | 97.30% |
| 2014-12-31 | $-0.05B | $-0.06B | 101.92% |
| 2014-09-30 | $-0.05B | $-0.06B | 335.71% |
| 2014-06-30 | $-0.04B | $-0.05B | -154.17% |
| 2014-03-31 | $-0.03B | $-0.05B | -45.90% |
| 2013-12-31 | $-0.02B | $0.10B | -17.39% |
| 2013-09-30 | $-0.02B | $0.10B | -16.16% |
| 2013-06-30 | $-0.02B | $0.10B | -15.92% |
| 2013-03-31 | $-0.02B | $0.10B | -19.26% |
| 2012-12-31 | $-0.02B | $0.10B | -26.23% |
| 2012-09-30 | $-0.02B | $0.10B | -29.12% |
| 2012-06-30 | $-0.02B | $0.05B | -35.02% |
| 2012-03-31 | $-0.02B | $0.05B | -36.52% |
| 2011-12-31 | $-0.03B | $0.06B | -50.20% |
| 2011-09-30 | $-0.03B | $0.06B | -12400.00% |
| 2011-06-30 | $-0.03B | $0.06B | 200.00% |
| 2011-03-31 | $-0.03B | $0.07B | 91.80% |
| 2010-12-31 | $-0.02B | $-0.19B | 35.60% |
| 2010-06-30 | $-0.02B | -288.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.431B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $28.621B | 33.10 |
| Tempus AI (TEM) | United States | $9.242B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $4.646B | 0.00 |
| Doximity (DOCS) | United States | $4.621B | 20.02 |
| Hims & Hers Health (HIMS) | United States | $3.711B | 30.18 |
| Hinge Health (HNGE) | United States | $3.065B | 0.00 |
| Privia Health (PRVA) | United States | $2.754B | 172.23 |
| 10x Genomics (TXG) | United States | $2.293B | 0.00 |
| Heartflow (HTFL) | United States | $1.759B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.736B | 23.16 |
| Omnicell (OMCL) | United States | $1.638B | 45.62 |
| Azenta (AZTA) | United States | $1.318B | 53.00 |
| Enovis (ENOV) | United States | $1.245B | 6.54 |
| Clover Health Investments (CLOV) | United States | $1.044B | 0.00 |
| Schrodinger (SDGR) | United States | $0.840B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.768B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.724B | 0.00 |
| Phreesia (PHR) | United States | $0.720B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Claritev (CTEV) | United States | $0.380B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.338B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| TruBridge (TBRG) | United States | $0.293B | 13.45 |
| Carlsmed (CARL) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.160B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.151B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 5.40 |
| American Well (AMWL) | United States | $0.088B | 0.00 |
| 111 (YI) | China | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.032B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.017B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.005B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |